1. Home
  2. ATXG vs CDT Comparison

ATXG vs CDT Comparison

Compare ATXG & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXG
  • CDT
  • Stock Information
  • Founded
  • ATXG 2014
  • CDT 2019
  • Country
  • ATXG China
  • CDT United States
  • Employees
  • ATXG N/A
  • CDT N/A
  • Industry
  • ATXG Professional Services
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATXG Consumer Discretionary
  • CDT Health Care
  • Exchange
  • ATXG Nasdaq
  • CDT Nasdaq
  • Market Cap
  • ATXG 5.4M
  • CDT 5.2M
  • IPO Year
  • ATXG N/A
  • CDT N/A
  • Fundamental
  • Price
  • ATXG $0.77
  • CDT $0.75
  • Analyst Decision
  • ATXG
  • CDT
  • Analyst Count
  • ATXG 0
  • CDT 0
  • Target Price
  • ATXG N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • ATXG 5.8K
  • CDT 1.4M
  • Earning Date
  • ATXG 02-14-2025
  • CDT 05-13-2025
  • Dividend Yield
  • ATXG N/A
  • CDT N/A
  • EPS Growth
  • ATXG N/A
  • CDT N/A
  • EPS
  • ATXG N/A
  • CDT N/A
  • Revenue
  • ATXG $4,549,310.00
  • CDT N/A
  • Revenue This Year
  • ATXG N/A
  • CDT N/A
  • Revenue Next Year
  • ATXG N/A
  • CDT N/A
  • P/E Ratio
  • ATXG N/A
  • CDT N/A
  • Revenue Growth
  • ATXG N/A
  • CDT N/A
  • 52 Week Low
  • ATXG $0.49
  • CDT $0.65
  • 52 Week High
  • ATXG $1.18
  • CDT $350.00
  • Technical
  • Relative Strength Index (RSI)
  • ATXG 41.97
  • CDT 33.47
  • Support Level
  • ATXG $0.81
  • CDT $0.76
  • Resistance Level
  • ATXG $0.89
  • CDT $1.05
  • Average True Range (ATR)
  • ATXG 0.06
  • CDT 0.14
  • MACD
  • ATXG -0.01
  • CDT 0.08
  • Stochastic Oscillator
  • ATXG 11.21
  • CDT 20.46

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: